So during this era of high vacancy, there was concern about a doom loop, where empty office spaces would crash property tax revenue, force budget cuts that ruin the whole city, and everything falls apart, and everything's horrible
Here come the lawyers Despite Novo Nordisks strategy of making clear how fragile generic supply chains are (a goal I share), I was surprised it took the pharma company so long to go after Hims & Hers specifically (maybe the lawyers were too busy saying that no, they meant to let their Canadian patent expire)
As a result, injectable forms yield better results since glutathione is transported through the bloodstream to those areas where it is required
Eli Lilly can charge a premium given the better weight loss numbers, but the GLP-1 market is getting crowded
not retracted as of 2026
If youre considering a GLP-1, the key is going in with your eyes open